Literature for PR-619 (DUB inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2019
1. Kuo,K.L., Liu,S.H., Lin,W.C., Chow,P.M., Chang,Y.W., Yang,S.P., Shi,C.S., Hsu,C.H., Liao,S.M., Chang,H.C. and Huang,K.H.
   The deubiquitinating enzyme inhibitor PR-619 enhances the cytotoxicity of cisplatin via the suppression of anti-apoptotic Bcl-2 protein: in vitro and in vivo study
   Cells8, PubMed  Europe PubMed DOI  I
2017
2. Ali,A., Raja,R., Farooqui,S.R., Ahmad,S. and Banerjea,A.C.
   USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein
   Biochem J474, 1653-1668. PubMed  Europe PubMed DOI  I
2011
3. Altun,M., Kramer,H.B., Willems,L.I., McDermott,J.L., Leach,C.A., Goldenberg,S.J., Kumar,K.G., Konietzny,R., Fischer,R., Kogan,E., Mackeen,M.M., McGouran,J., Khoronenkova,S.V., Parsons,J.L., Dianov,G.L., Nicholson,B. and Kessler,B.M.
   Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes
   Chem Biol18, 1401-1412. PubMed  Europe PubMed DOI  I